Zobrazeno 1 - 8
of 8
pro vyhledávání: '"JM Gooya"'
Publikováno v:
Blood. 84:125-132
Interleukin-1 (IL-1) has been shown to stimulate hematopoietic progenitor cell growth both in vitro and in vivo. Although IL-1 alone lacks the ability to promote hematopoietic progenitor growth in vitro, it is a potent synergistic factor in combinati
Publikováno v:
Blood. 88(3)
Because leukemia inhibitory factor (LIF) has little or no effect on murine hematopoietic progenitor cell growth yet enhances hematopoiesis in vivo, we sought to determine whether the effects of LIF were directly or indirectly mediated, or a combinati
Publikováno v:
Europe PubMed Central
The present studies investigated the balance of positive and negative growth signals in direct regulation of hematopoiesis. Interleukin-3 (IL-3) combined with Steel factor (SLF) optimally stimulated proliferation of Lin-Thy-1+ murine bone marrow prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ffeea2a747f355c4794138e93548a76e
http://europepmc.org/abstract/med/7522186
http://europepmc.org/abstract/med/7522186
Autor:
Jr, Keller, Sh, Bartelmez, Sitnicka E, Fw, Ruscetti, Ortiz M, Jm, Gooya, Sten Eirik Waelgaard Jacobsen
Publikováno v:
Europe PubMed Central
Both transforming growth factor beta (TGF beta) and macrophage inflammatory protein 1 alpha (MIP-1 alpha) have been shown to be multifunctional regulators of hematopoiesis that can either inhibit or enhance the growth of hematopoietic progenitor cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1046ac46d529a4a1a2b3824a8085fa23
http://europepmc.org/abstract/med/7919333
http://europepmc.org/abstract/med/7919333
Publikováno v:
Stem Cells & Development; Apr2016, Vol. 25 Issue 8, p575-585, 11p
Autor:
Ludlow, Louise E., Hii, Linda L., Thorpe, Janine, Newbold, Andrea, Tainton, Kellie M., Trapani, Joseph A., Clarke, Christopher J.P., Johnstone, Ricky W.
Publikováno v:
Journal of Cellular Biochemistry; Mar2008, Vol. 103 Issue 4, p1270-1282, 13p
Autor:
Stanley T. Crooke
This state-of-the-art reference provides comprehensive coverage of the development of antisense oligonucleotides to inhibit cancer cells as well as those involved in infectious, inflammatory, and immune-mediated diseases-highlighting new tools and te